img

Global Menopausal Hot Flashes Medicines Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Menopausal Hot Flashes Medicines Market Research Report 2024

According to Mr Accuracy reports’s new survey, global Menopausal Hot Flashes Medicines market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Menopausal Hot Flashes Medicines market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Menopausal Hot Flashes Medicines market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Pfizer
Allergan
Bayer
Besins Healthcare
Endoceutics
Fervent Pharmaceuticals
GlaxoSmithKline
Hisamitsu Pharmaceutical
iHealth Labs
Merck
Millendo Therapeutics
Mithra Pharmaceuticals
Mitsubishi Tanabe Pharma
Mylan
Nerre Therapeutics
Novartis
Novo Nordisk
Ogeda
Pherin Pharmaceuticals
Teva Pharmaceutical
TherapeuticsMD
Segment by Type
Hormonal Medicines
Non-Hormonal Medicines
Complementary Alternative Medicines

Segment by Application


Hospital
Retail
Online

Consumption by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Menopausal Hot Flashes Medicines report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 Menopausal Hot Flashes Medicines Market Overview
1.1 Product Overview and Scope of Menopausal Hot Flashes Medicines
1.2 Menopausal Hot Flashes Medicines Segment by Type
1.2.1 Global Menopausal Hot Flashes Medicines Market Value Comparison by Type (2024-2034)
1.2.2 Hormonal Medicines
1.2.3 Non-Hormonal Medicines
1.2.4 Complementary Alternative Medicines
1.3 Menopausal Hot Flashes Medicines Segment by Application
1.3.1 Global Menopausal Hot Flashes Medicines Market Value by Application: (2024-2034)
1.3.2 Hospital
1.3.3 Retail
1.3.4 Online
1.4 Global Menopausal Hot Flashes Medicines Market Size Estimates and Forecasts
1.4.1 Global Menopausal Hot Flashes Medicines Revenue 2018-2029
1.4.2 Global Menopausal Hot Flashes Medicines Sales 2018-2029
1.4.3 Global Menopausal Hot Flashes Medicines Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Menopausal Hot Flashes Medicines Market Competition by Manufacturers
2.1 Global Menopausal Hot Flashes Medicines Sales Market Share by Manufacturers (2018-2024)
2.2 Global Menopausal Hot Flashes Medicines Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Menopausal Hot Flashes Medicines Average Price by Manufacturers (2018-2024)
2.4 Global Menopausal Hot Flashes Medicines Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Menopausal Hot Flashes Medicines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Menopausal Hot Flashes Medicines, Product Type & Application
2.7 Menopausal Hot Flashes Medicines Market Competitive Situation and Trends
2.7.1 Menopausal Hot Flashes Medicines Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Menopausal Hot Flashes Medicines Players Market Share by Revenue
2.7.3 Global Menopausal Hot Flashes Medicines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Menopausal Hot Flashes Medicines Retrospective Market Scenario by Region
3.1 Global Menopausal Hot Flashes Medicines Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Menopausal Hot Flashes Medicines Global Menopausal Hot Flashes Medicines Sales by Region: 2018-2029
3.2.1 Global Menopausal Hot Flashes Medicines Sales by Region: 2018-2024
3.2.2 Global Menopausal Hot Flashes Medicines Sales by Region: 2024-2029
3.3 Global Menopausal Hot Flashes Medicines Global Menopausal Hot Flashes Medicines Revenue by Region: 2018-2029
3.3.1 Global Menopausal Hot Flashes Medicines Revenue by Region: 2018-2024
3.3.2 Global Menopausal Hot Flashes Medicines Revenue by Region: 2024-2029
3.4 North America Menopausal Hot Flashes Medicines Market Facts & Figures by Country
3.4.1 North America Menopausal Hot Flashes Medicines Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Menopausal Hot Flashes Medicines Sales by Country (2018-2029)
3.4.3 North America Menopausal Hot Flashes Medicines Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Menopausal Hot Flashes Medicines Market Facts & Figures by Country
3.5.1 Europe Menopausal Hot Flashes Medicines Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Menopausal Hot Flashes Medicines Sales by Country (2018-2029)
3.5.3 Europe Menopausal Hot Flashes Medicines Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Menopausal Hot Flashes Medicines Market Facts & Figures by Country
3.6.1 Asia Pacific Menopausal Hot Flashes Medicines Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Menopausal Hot Flashes Medicines Sales by Country (2018-2029)
3.6.3 Asia Pacific Menopausal Hot Flashes Medicines Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Menopausal Hot Flashes Medicines Market Facts & Figures by Country
3.7.1 Latin America Menopausal Hot Flashes Medicines Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Menopausal Hot Flashes Medicines Sales by Country (2018-2029)
3.7.3 Latin America Menopausal Hot Flashes Medicines Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Menopausal Hot Flashes Medicines Market Facts & Figures by Country
3.8.1 Middle East and Africa Menopausal Hot Flashes Medicines Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Menopausal Hot Flashes Medicines Sales by Country (2018-2029)
3.8.3 Middle East and Africa Menopausal Hot Flashes Medicines Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Menopausal Hot Flashes Medicines Sales by Type (2018-2029)
4.1.1 Global Menopausal Hot Flashes Medicines Sales by Type (2018-2024)
4.1.2 Global Menopausal Hot Flashes Medicines Sales by Type (2024-2029)
4.1.3 Global Menopausal Hot Flashes Medicines Sales Market Share by Type (2018-2029)
4.2 Global Menopausal Hot Flashes Medicines Revenue by Type (2018-2029)
4.2.1 Global Menopausal Hot Flashes Medicines Revenue by Type (2018-2024)
4.2.2 Global Menopausal Hot Flashes Medicines Revenue by Type (2024-2029)
4.2.3 Global Menopausal Hot Flashes Medicines Revenue Market Share by Type (2018-2029)
4.3 Global Menopausal Hot Flashes Medicines Price by Type (2018-2029)
5 Segment by Application
5.1 Global Menopausal Hot Flashes Medicines Sales by Application (2018-2029)
5.1.1 Global Menopausal Hot Flashes Medicines Sales by Application (2018-2024)
5.1.2 Global Menopausal Hot Flashes Medicines Sales by Application (2024-2029)
5.1.3 Global Menopausal Hot Flashes Medicines Sales Market Share by Application (2018-2029)
5.2 Global Menopausal Hot Flashes Medicines Revenue by Application (2018-2029)
5.2.1 Global Menopausal Hot Flashes Medicines Revenue by Application (2018-2024)
5.2.2 Global Menopausal Hot Flashes Medicines Revenue by Application (2024-2029)
5.2.3 Global Menopausal Hot Flashes Medicines Revenue Market Share by Application (2018-2029)
5.3 Global Menopausal Hot Flashes Medicines Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Menopausal Hot Flashes Medicines Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Pfizer Menopausal Hot Flashes Medicines Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Allergan
6.2.1 Allergan Corporation Information
6.2.2 Allergan Description and Business Overview
6.2.3 Allergan Menopausal Hot Flashes Medicines Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Allergan Menopausal Hot Flashes Medicines Product Portfolio
6.2.5 Allergan Recent Developments/Updates
6.3 Bayer
6.3.1 Bayer Corporation Information
6.3.2 Bayer Description and Business Overview
6.3.3 Bayer Menopausal Hot Flashes Medicines Sales, Revenue and Gross Margin (2018-2024)
6.3.4 Bayer Menopausal Hot Flashes Medicines Product Portfolio
6.3.5 Bayer Recent Developments/Updates
6.4 Besins Healthcare
6.4.1 Besins Healthcare Corporation Information
6.4.2 Besins Healthcare Description and Business Overview
6.4.3 Besins Healthcare Menopausal Hot Flashes Medicines Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Besins Healthcare Menopausal Hot Flashes Medicines Product Portfolio
6.4.5 Besins Healthcare Recent Developments/Updates
6.5 Endoceutics
6.5.1 Endoceutics Corporation Information
6.5.2 Endoceutics Description and Business Overview
6.5.3 Endoceutics Menopausal Hot Flashes Medicines Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Endoceutics Menopausal Hot Flashes Medicines Product Portfolio
6.5.5 Endoceutics Recent Developments/Updates
6.6 Fervent Pharmaceuticals
6.6.1 Fervent Pharmaceuticals Corporation Information
6.6.2 Fervent Pharmaceuticals Description and Business Overview
6.6.3 Fervent Pharmaceuticals Menopausal Hot Flashes Medicines Sales, Revenue and Gross Margin (2018-2024)
6.6.4 Fervent Pharmaceuticals Menopausal Hot Flashes Medicines Product Portfolio
6.6.5 Fervent Pharmaceuticals Recent Developments/Updates
6.7 GlaxoSmithKline
6.6.1 GlaxoSmithKline Corporation Information
6.6.2 GlaxoSmithKline Description and Business Overview
6.6.3 GlaxoSmithKline Menopausal Hot Flashes Medicines Sales, Revenue and Gross Margin (2018-2024)
6.4.4 GlaxoSmithKline Menopausal Hot Flashes Medicines Product Portfolio
6.7.5 GlaxoSmithKline Recent Developments/Updates
6.8 Hisamitsu Pharmaceutical
6.8.1 Hisamitsu Pharmaceutical Corporation Information
6.8.2 Hisamitsu Pharmaceutical Description and Business Overview
6.8.3 Hisamitsu Pharmaceutical Menopausal Hot Flashes Medicines Sales, Revenue and Gross Margin (2018-2024)
6.8.4 Hisamitsu Pharmaceutical Menopausal Hot Flashes Medicines Product Portfolio
6.8.5 Hisamitsu Pharmaceutical Recent Developments/Updates
6.9 iHealth Labs
6.9.1 iHealth Labs Corporation Information
6.9.2 iHealth Labs Description and Business Overview
6.9.3 iHealth Labs Menopausal Hot Flashes Medicines Sales, Revenue and Gross Margin (2018-2024)
6.9.4 iHealth Labs Menopausal Hot Flashes Medicines Product Portfolio
6.9.5 iHealth Labs Recent Developments/Updates
6.10 Merck
6.10.1 Merck Corporation Information
6.10.2 Merck Description and Business Overview
6.10.3 Merck Menopausal Hot Flashes Medicines Sales, Revenue and Gross Margin (2018-2024)
6.10.4 Merck Menopausal Hot Flashes Medicines Product Portfolio
6.10.5 Merck Recent Developments/Updates
6.11 Millendo Therapeutics
6.11.1 Millendo Therapeutics Corporation Information
6.11.2 Millendo Therapeutics Menopausal Hot Flashes Medicines Description and Business Overview
6.11.3 Millendo Therapeutics Menopausal Hot Flashes Medicines Sales, Revenue and Gross Margin (2018-2024)
6.11.4 Millendo Therapeutics Menopausal Hot Flashes Medicines Product Portfolio
6.11.5 Millendo Therapeutics Recent Developments/Updates
6.12 Mithra Pharmaceuticals
6.12.1 Mithra Pharmaceuticals Corporation Information
6.12.2 Mithra Pharmaceuticals Menopausal Hot Flashes Medicines Description and Business Overview
6.12.3 Mithra Pharmaceuticals Menopausal Hot Flashes Medicines Sales, Revenue and Gross Margin (2018-2024)
6.12.4 Mithra Pharmaceuticals Menopausal Hot Flashes Medicines Product Portfolio
6.12.5 Mithra Pharmaceuticals Recent Developments/Updates
6.13 Mitsubishi Tanabe Pharma
6.13.1 Mitsubishi Tanabe Pharma Corporation Information
6.13.2 Mitsubishi Tanabe Pharma Menopausal Hot Flashes Medicines Description and Business Overview
6.13.3 Mitsubishi Tanabe Pharma Menopausal Hot Flashes Medicines Sales, Revenue and Gross Margin (2018-2024)
6.13.4 Mitsubishi Tanabe Pharma Menopausal Hot Flashes Medicines Product Portfolio
6.13.5 Mitsubishi Tanabe Pharma Recent Developments/Updates
6.14 Mylan
6.14.1 Mylan Corporation Information
6.14.2 Mylan Menopausal Hot Flashes Medicines Description and Business Overview
6.14.3 Mylan Menopausal Hot Flashes Medicines Sales, Revenue and Gross Margin (2018-2024)
6.14.4 Mylan Menopausal Hot Flashes Medicines Product Portfolio
6.14.5 Mylan Recent Developments/Updates
6.15 Nerre Therapeutics
6.15.1 Nerre Therapeutics Corporation Information
6.15.2 Nerre Therapeutics Menopausal Hot Flashes Medicines Description and Business Overview
6.15.3 Nerre Therapeutics Menopausal Hot Flashes Medicines Sales, Revenue and Gross Margin (2018-2024)
6.15.4 Nerre Therapeutics Menopausal Hot Flashes Medicines Product Portfolio
6.15.5 Nerre Therapeutics Recent Developments/Updates
6.16 Novartis
6.16.1 Novartis Corporation Information
6.16.2 Novartis Menopausal Hot Flashes Medicines Description and Business Overview
6.16.3 Novartis Menopausal Hot Flashes Medicines Sales, Revenue and Gross Margin (2018-2024)
6.16.4 Novartis Menopausal Hot Flashes Medicines Product Portfolio
6.16.5 Novartis Recent Developments/Updates
6.17 Novo Nordisk
6.17.1 Novo Nordisk Corporation Information
6.17.2 Novo Nordisk Menopausal Hot Flashes Medicines Description and Business Overview
6.17.3 Novo Nordisk Menopausal Hot Flashes Medicines Sales, Revenue and Gross Margin (2018-2024)
6.17.4 Novo Nordisk Menopausal Hot Flashes Medicines Product Portfolio
6.17.5 Novo Nordisk Recent Developments/Updates
6.18 Ogeda
6.18.1 Ogeda Corporation Information
6.18.2 Ogeda Menopausal Hot Flashes Medicines Description and Business Overview
6.18.3 Ogeda Menopausal Hot Flashes Medicines Sales, Revenue and Gross Margin (2018-2024)
6.18.4 Ogeda Menopausal Hot Flashes Medicines Product Portfolio
6.18.5 Ogeda Recent Developments/Updates
6.19 Pherin Pharmaceuticals
6.19.1 Pherin Pharmaceuticals Corporation Information
6.19.2 Pherin Pharmaceuticals Menopausal Hot Flashes Medicines Description and Business Overview
6.19.3 Pherin Pharmaceuticals Menopausal Hot Flashes Medicines Sales, Revenue and Gross Margin (2018-2024)
6.19.4 Pherin Pharmaceuticals Menopausal Hot Flashes Medicines Product Portfolio
6.19.5 Pherin Pharmaceuticals Recent Developments/Updates
6.20 Teva Pharmaceutical
6.20.1 Teva Pharmaceutical Corporation Information
6.20.2 Teva Pharmaceutical Menopausal Hot Flashes Medicines Description and Business Overview
6.20.3 Teva Pharmaceutical Menopausal Hot Flashes Medicines Sales, Revenue and Gross Margin (2018-2024)
6.20.4 Teva Pharmaceutical Menopausal Hot Flashes Medicines Product Portfolio
6.20.5 Teva Pharmaceutical Recent Developments/Updates
6.21 TherapeuticsMD
6.21.1 TherapeuticsMD Corporation Information
6.21.2 TherapeuticsMD Menopausal Hot Flashes Medicines Description and Business Overview
6.21.3 TherapeuticsMD Menopausal Hot Flashes Medicines Sales, Revenue and Gross Margin (2018-2024)
6.21.4 TherapeuticsMD Menopausal Hot Flashes Medicines Product Portfolio
6.21.5 TherapeuticsMD Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Menopausal Hot Flashes Medicines Industry Chain Analysis
7.2 Menopausal Hot Flashes Medicines Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Menopausal Hot Flashes Medicines Production Mode & Process
7.4 Menopausal Hot Flashes Medicines Sales and Marketing
7.4.1 Menopausal Hot Flashes Medicines Sales Channels
7.4.2 Menopausal Hot Flashes Medicines Distributors
7.5 Menopausal Hot Flashes Medicines Customers
8 Menopausal Hot Flashes Medicines Market Dynamics
8.1 Menopausal Hot Flashes Medicines Industry Trends
8.2 Menopausal Hot Flashes Medicines Market Drivers
8.3 Menopausal Hot Flashes Medicines Market Challenges
8.4 Menopausal Hot Flashes Medicines Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Menopausal Hot Flashes Medicines Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Menopausal Hot Flashes Medicines Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Menopausal Hot Flashes Medicines Market Competitive Situation by Manufacturers in 2022
Table 4. Global Menopausal Hot Flashes Medicines Sales (K Units) of Key Manufacturers (2018-2024)
Table 5. Global Menopausal Hot Flashes Medicines Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Menopausal Hot Flashes Medicines Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Menopausal Hot Flashes Medicines Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Menopausal Hot Flashes Medicines Average Price (US$/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Menopausal Hot Flashes Medicines, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Menopausal Hot Flashes Medicines, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Menopausal Hot Flashes Medicines, Product Type & Application
Table 12. Global Key Manufacturers of Menopausal Hot Flashes Medicines, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Menopausal Hot Flashes Medicines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Menopausal Hot Flashes Medicines as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Menopausal Hot Flashes Medicines Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Menopausal Hot Flashes Medicines Sales by Region (2018-2024) & (K Units)
Table 18. Global Menopausal Hot Flashes Medicines Sales Market Share by Region (2018-2024)
Table 19. Global Menopausal Hot Flashes Medicines Sales by Region (2024-2029) & (K Units)
Table 20. Global Menopausal Hot Flashes Medicines Sales Market Share by Region (2024-2029)
Table 21. Global Menopausal Hot Flashes Medicines Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Menopausal Hot Flashes Medicines Revenue Market Share by Region (2018-2024)
Table 23. Global Menopausal Hot Flashes Medicines Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Menopausal Hot Flashes Medicines Revenue Market Share by Region (2024-2029)
Table 25. North America Menopausal Hot Flashes Medicines Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Menopausal Hot Flashes Medicines Sales by Country (2018-2024) & (K Units)
Table 27. North America Menopausal Hot Flashes Medicines Sales by Country (2024-2029) & (K Units)
Table 28. North America Menopausal Hot Flashes Medicines Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Menopausal Hot Flashes Medicines Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Menopausal Hot Flashes Medicines Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Menopausal Hot Flashes Medicines Sales by Country (2018-2024) & (K Units)
Table 32. Europe Menopausal Hot Flashes Medicines Sales by Country (2024-2029) & (K Units)
Table 33. Europe Menopausal Hot Flashes Medicines Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Menopausal Hot Flashes Medicines Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Menopausal Hot Flashes Medicines Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Menopausal Hot Flashes Medicines Sales by Region (2018-2024) & (K Units)
Table 37. Asia Pacific Menopausal Hot Flashes Medicines Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Menopausal Hot Flashes Medicines Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Menopausal Hot Flashes Medicines Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Menopausal Hot Flashes Medicines Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Menopausal Hot Flashes Medicines Sales by Country (2018-2024) & (K Units)
Table 42. Latin America Menopausal Hot Flashes Medicines Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Menopausal Hot Flashes Medicines Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Menopausal Hot Flashes Medicines Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Menopausal Hot Flashes Medicines Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Menopausal Hot Flashes Medicines Sales by Country (2018-2024) & (K Units)
Table 47. Middle East & Africa Menopausal Hot Flashes Medicines Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Menopausal Hot Flashes Medicines Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Menopausal Hot Flashes Medicines Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Menopausal Hot Flashes Medicines Sales (K Units) by Type (2018-2024)
Table 51. Global Menopausal Hot Flashes Medicines Sales (K Units) by Type (2024-2029)
Table 52. Global Menopausal Hot Flashes Medicines Sales Market Share by Type (2018-2024)
Table 53. Global Menopausal Hot Flashes Medicines Sales Market Share by Type (2024-2029)
Table 54. Global Menopausal Hot Flashes Medicines Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Menopausal Hot Flashes Medicines Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Menopausal Hot Flashes Medicines Revenue Market Share by Type (2018-2024)
Table 57. Global Menopausal Hot Flashes Medicines Revenue Market Share by Type (2024-2029)
Table 58. Global Menopausal Hot Flashes Medicines Price (US$/Unit) by Type (2018-2024)
Table 59. Global Menopausal Hot Flashes Medicines Price (US$/Unit) by Type (2024-2029)
Table 60. Global Menopausal Hot Flashes Medicines Sales (K Units) by Application (2018-2024)
Table 61. Global Menopausal Hot Flashes Medicines Sales (K Units) by Application (2024-2029)
Table 62. Global Menopausal Hot Flashes Medicines Sales Market Share by Application (2018-2024)
Table 63. Global Menopausal Hot Flashes Medicines Sales Market Share by Application (2024-2029)
Table 64. Global Menopausal Hot Flashes Medicines Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Menopausal Hot Flashes Medicines Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Menopausal Hot Flashes Medicines Revenue Market Share by Application (2018-2024)
Table 67. Global Menopausal Hot Flashes Medicines Revenue Market Share by Application (2024-2029)
Table 68. Global Menopausal Hot Flashes Medicines Price (US$/Unit) by Application (2018-2024)
Table 69. Global Menopausal Hot Flashes Medicines Price (US$/Unit) by Application (2024-2029)
Table 70. Pfizer Corporation Information
Table 71. Pfizer Description and Business Overview
Table 72. Pfizer Menopausal Hot Flashes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 73. Pfizer Menopausal Hot Flashes Medicines Product
Table 74. Pfizer Recent Developments/Updates
Table 75. Allergan Corporation Information
Table 76. Allergan Description and Business Overview
Table 77. Allergan Menopausal Hot Flashes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 78. Allergan Menopausal Hot Flashes Medicines Product
Table 79. Allergan Recent Developments/Updates
Table 80. Bayer Corporation Information
Table 81. Bayer Description and Business Overview
Table 82. Bayer Menopausal Hot Flashes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 83. Bayer Menopausal Hot Flashes Medicines Product
Table 84. Bayer Recent Developments/Updates
Table 85. Besins Healthcare Corporation Information
Table 86. Besins Healthcare Description and Business Overview
Table 87. Besins Healthcare Menopausal Hot Flashes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 88. Besins Healthcare Menopausal Hot Flashes Medicines Product
Table 89. Besins Healthcare Recent Developments/Updates
Table 90. Endoceutics Corporation Information
Table 91. Endoceutics Description and Business Overview
Table 92. Endoceutics Menopausal Hot Flashes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 93. Endoceutics Menopausal Hot Flashes Medicines Product
Table 94. Endoceutics Recent Developments/Updates
Table 95. Fervent Pharmaceuticals Corporation Information
Table 96. Fervent Pharmaceuticals Description and Business Overview
Table 97. Fervent Pharmaceuticals Menopausal Hot Flashes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 98. Fervent Pharmaceuticals Menopausal Hot Flashes Medicines Product
Table 99. Fervent Pharmaceuticals Recent Developments/Updates
Table 100. GlaxoSmithKline Corporation Information
Table 101. GlaxoSmithKline Description and Business Overview
Table 102. GlaxoSmithKline Menopausal Hot Flashes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 103. GlaxoSmithKline Menopausal Hot Flashes Medicines Product
Table 104. GlaxoSmithKline Recent Developments/Updates
Table 105. Hisamitsu Pharmaceutical Corporation Information
Table 106. Hisamitsu Pharmaceutical Description and Business Overview
Table 107. Hisamitsu Pharmaceutical Menopausal Hot Flashes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 108. Hisamitsu Pharmaceutical Menopausal Hot Flashes Medicines Product
Table 109. Hisamitsu Pharmaceutical Recent Developments/Updates
Table 110. iHealth Labs Corporation Information
Table 111. iHealth Labs Description and Business Overview
Table 112. iHealth Labs Menopausal Hot Flashes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 113. iHealth Labs Menopausal Hot Flashes Medicines Product
Table 114. iHealth Labs Recent Developments/Updates
Table 115. Merck Corporation Information
Table 116. Merck Description and Business Overview
Table 117. Merck Menopausal Hot Flashes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 118. Merck Menopausal Hot Flashes Medicines Product
Table 119. Merck Recent Developments/Updates
Table 120. Millendo Therapeutics Corporation Information
Table 121. Millendo Therapeutics Description and Business Overview
Table 122. Millendo Therapeutics Menopausal Hot Flashes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 123. Millendo Therapeutics Menopausal Hot Flashes Medicines Product
Table 124. Millendo Therapeutics Recent Developments/Updates
Table 125. Mithra Pharmaceuticals Corporation Information
Table 126. Mithra Pharmaceuticals Description and Business Overview
Table 127. Mithra Pharmaceuticals Menopausal Hot Flashes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 128. Mithra Pharmaceuticals Menopausal Hot Flashes Medicines Product
Table 129. Mithra Pharmaceuticals Recent Developments/Updates
Table 130. Mitsubishi Tanabe Pharma Corporation Information
Table 131. Mitsubishi Tanabe Pharma Description and Business Overview
Table 132. Mitsubishi Tanabe Pharma Menopausal Hot Flashes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 133. Mitsubishi Tanabe Pharma Menopausal Hot Flashes Medicines Product
Table 134. Mitsubishi Tanabe Pharma Recent Developments/Updates
Table 135. Mylan Corporation Information
Table 136. Mylan Description and Business Overview
Table 137. Mylan Menopausal Hot Flashes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 138. Mylan Menopausal Hot Flashes Medicines Product
Table 139. Mylan Recent Developments/Updates
Table 140. Nerre Therapeutics Corporation Information
Table 141. Nerre Therapeutics Description and Business Overview
Table 142. Nerre Therapeutics Menopausal Hot Flashes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 143. Nerre Therapeutics Menopausal Hot Flashes Medicines Product
Table 144. Nerre Therapeutics Recent Developments/Updates
Table 145. Novartis Corporation Information
Table 146. Novartis Description and Business Overview
Table 147. Novartis Menopausal Hot Flashes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 148. Novartis Menopausal Hot Flashes Medicines Product
Table 149. Novartis Recent Developments/Updates
Table 150. Novo Nordisk Corporation Information
Table 151. Novo Nordisk Description and Business Overview
Table 152. Novo Nordisk Menopausal Hot Flashes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 153. Novo Nordisk Menopausal Hot Flashes Medicines Product
Table 154. Novo Nordisk Recent Developments/Updates
Table 155. Ogeda Corporation Information
Table 156. Ogeda Description and Business Overview
Table 157. Ogeda Menopausal Hot Flashes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 158. Ogeda Menopausal Hot Flashes Medicines Product
Table 159. Ogeda Recent Developments/Updates
Table 160. Pherin Pharmaceuticals Corporation Information
Table 161. Pherin Pharmaceuticals Description and Business Overview
Table 162. Pherin Pharmaceuticals Menopausal Hot Flashes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 163. Pherin Pharmaceuticals Menopausal Hot Flashes Medicines Product
Table 164. Pherin Pharmaceuticals Recent Developments/Updates
Table 165. Teva Pharmaceutical Corporation Information
Table 166. Teva Pharmaceutical Description and Business Overview
Table 167. Teva Pharmaceutical Menopausal Hot Flashes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 168. Teva Pharmaceutical Menopausal Hot Flashes Medicines Product
Table 169. Teva Pharmaceutical Recent Developments/Updates
Table 170. TherapeuticsMD Corporation Information
Table 171. TherapeuticsMD Description and Business Overview
Table 172. TherapeuticsMD Menopausal Hot Flashes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 173. TherapeuticsMD Menopausal Hot Flashes Medicines Product
Table 174. TherapeuticsMD Recent Developments/Updates
Table 175. Key Raw Materials Lists
Table 176. Raw Materials Key Suppliers Lists
Table 177. Menopausal Hot Flashes Medicines Distributors List
Table 178. Menopausal Hot Flashes Medicines Customers List
Table 179. Menopausal Hot Flashes Medicines Market Trends
Table 180. Menopausal Hot Flashes Medicines Market Drivers
Table 181. Menopausal Hot Flashes Medicines Market Challenges
Table 182. Menopausal Hot Flashes Medicines Market Restraints
Table 183. Research Programs/Design for This Report
Table 184. Key Data Information from Secondary Sources
Table 185. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Menopausal Hot Flashes Medicines
Figure 2. Global Menopausal Hot Flashes Medicines Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Menopausal Hot Flashes Medicines Market Share by Type in 2022 & 2029
Figure 4. Hormonal Medicines Product Picture
Figure 5. Non-Hormonal Medicines Product Picture
Figure 6. Complementary Alternative Medicines Product Picture
Figure 7. Global Menopausal Hot Flashes Medicines Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 8. Global Menopausal Hot Flashes Medicines Market Share by Application in 2022 & 2029
Figure 9. Hospital
Figure 10. Retail
Figure 11. Online
Figure 12. Global Menopausal Hot Flashes Medicines Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Menopausal Hot Flashes Medicines Market Size (2018-2029) & (US$ Million)
Figure 14. Global Menopausal Hot Flashes Medicines Sales (2018-2029) & (K Units)
Figure 15. Global Menopausal Hot Flashes Medicines Average Price (US$/Unit) & (2018-2029)
Figure 16. Menopausal Hot Flashes Medicines Report Years Considered
Figure 17. Menopausal Hot Flashes Medicines Sales Share by Manufacturers in 2022
Figure 18. Global Menopausal Hot Flashes Medicines Revenue Share by Manufacturers in 2022
Figure 19. The Global 5 and 10 Largest Menopausal Hot Flashes Medicines Players: Market Share by Revenue in 2022
Figure 20. Menopausal Hot Flashes Medicines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 21. Global Menopausal Hot Flashes Medicines Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 22. North America Menopausal Hot Flashes Medicines Sales Market Share by Country (2018-2029)
Figure 23. North America Menopausal Hot Flashes Medicines Revenue Market Share by Country (2018-2029)
Figure 24. United States Menopausal Hot Flashes Medicines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Canada Menopausal Hot Flashes Medicines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Europe Menopausal Hot Flashes Medicines Sales Market Share by Country (2018-2029)
Figure 27. Europe Menopausal Hot Flashes Medicines Revenue Market Share by Country (2018-2029)
Figure 28. Germany Menopausal Hot Flashes Medicines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. France Menopausal Hot Flashes Medicines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. U.K. Menopausal Hot Flashes Medicines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Italy Menopausal Hot Flashes Medicines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Russia Menopausal Hot Flashes Medicines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Asia Pacific Menopausal Hot Flashes Medicines Sales Market Share by Region (2018-2029)
Figure 34. Asia Pacific Menopausal Hot Flashes Medicines Revenue Market Share by Region (2018-2029)
Figure 35. China Menopausal Hot Flashes Medicines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Japan Menopausal Hot Flashes Medicines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. South Korea Menopausal Hot Flashes Medicines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. India Menopausal Hot Flashes Medicines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Australia Menopausal Hot Flashes Medicines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. China Taiwan Menopausal Hot Flashes Medicines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Southeast Asia Menopausal Hot Flashes Medicines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Latin America Menopausal Hot Flashes Medicines Sales Market Share by Country (2018-2029)
Figure 43. Latin America Menopausal Hot Flashes Medicines Revenue Market Share by Country (2018-2029)
Figure 44. Mexico Menopausal Hot Flashes Medicines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Brazil Menopausal Hot Flashes Medicines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Argentina Menopausal Hot Flashes Medicines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Middle East & Africa Menopausal Hot Flashes Medicines Sales Market Share by Country (2018-2029)
Figure 48. Middle East & Africa Menopausal Hot Flashes Medicines Revenue Market Share by Country (2018-2029)
Figure 49. Turkey Menopausal Hot Flashes Medicines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Saudi Arabia Menopausal Hot Flashes Medicines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. UAE Menopausal Hot Flashes Medicines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Global Sales Market Share of Menopausal Hot Flashes Medicines by Type (2018-2029)
Figure 53. Global Revenue Market Share of Menopausal Hot Flashes Medicines by Type (2018-2029)
Figure 54. Global Menopausal Hot Flashes Medicines Price (US$/Unit) by Type (2018-2029)
Figure 55. Global Sales Market Share of Menopausal Hot Flashes Medicines by Application (2018-2029)
Figure 56. Global Revenue Market Share of Menopausal Hot Flashes Medicines by Application (2018-2029)
Figure 57. Global Menopausal Hot Flashes Medicines Price (US$/Unit) by Application (2018-2029)
Figure 58. Menopausal Hot Flashes Medicines Value Chain
Figure 59. Menopausal Hot Flashes Medicines Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed